Cytomx Therapeutics

Business Services · California, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

151 Oyster Point Blvd Ste 400, South San...

Phone Number

(650) 515-3185

Revenue

$18.3 Million

Stock Symbol

CTMX

Industry

Business Services Research & Development

About Cytomx Therapeutics

CytomX Therapeutics is a NASDAQ-listed clinical-stage biopharmaceutical company dedicated to revolutionizing oncology treatments. The company utilizes its proprietary Probody® therapeutic platform to develop conditionally activated, masked biologic drugs. This technology is designed to localize drug activity specifically to the tumor microenvironment, thereby increasing efficacy against cancer while minimizing damage and toxicity to healthy tissues throughout the rest of the body. CytomX's robust pipeline includes Probody drug conjugates (ADCs) and T-cell engaging bispecific antibodies, targeting unmet needs in solid tumors and other cancers. The company operates on a hybrid business model, generating revenue through extensive R&D and milestone payments from major strategic partnerships with pharmaceutical leaders like Bristol Myers Squibb and Amgen.Explore more
Cytomx Therapeutics's Social MediaSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: CTMXShow more

Cytomx Therapeutics Org Chart

PhoneEmail
YC
United States flag for contact location.

Senior Vice President, Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Cytomx Therapeutics

Compare insights from companies similar to Cytomx Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Cytomx Therapeutics

$18.3M
51-200
Public
$341.2M
2008
YC
Yu-Waye ChuSenior Vice President, Chief Medical Officer
$234.1M
51-200
Public
-
2015
YH
Yujiro HataCEO & Founder
$96.4M
201-500
Private
$30M
2000
JS
Jennifer SanfilippoGeneral Counsel & Chief Compliance Officer
$45.7M
51-200
Public
$180.4M
2003
$35M
51-200
Public
$425M
2015
AH
Andrew HirschPresident & CEO
$21.1M
51-200
Private
-
2012
Illustration of an envelope

Cytomx Therapeutics Tech Stack

A closer look at the technologies used by Cytomx Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding Cytomx Therapeutics

What is Cytomx Therapeutics's stock symbol?
Cytomx Therapeutics's stock symbol is CTMX
What is Cytomx Therapeutics's official website?
Cytomx Therapeutics's official website is www.cytomx.com
What is Cytomx Therapeutics's Revenue?
Cytomx Therapeutics's revenue is $18.3 Million
What is Cytomx Therapeutics's SIC code?
Cytomx Therapeutics's SIC: 87,873
What is Cytomx Therapeutics's NAICS code?
Cytomx Therapeutics's NAICS: 54,541
How many employees does Cytomx Therapeutics have?
Cytomx Therapeutics has 51-200 employees
What industry does Cytomx Therapeutics belong to?
Cytomx Therapeutics is in the industry of: Business Services, Research & Development
What is Cytomx Therapeutics competition?
Cytomx Therapeutics top competitors include: Sutro Biopharma, IDEAYA Biosciences, C4 Therapeutics, Myonex
What technology does Cytomx Therapeutics use?
Some of the popular technologies that Cytomx Therapeutics uses are: DocuSign, WordPress.org, PHP, Microsoft SharePoint
How do I contact Cytomx Therapeutics?
Cytomx Therapeutics contact info: Phone number: (650) 515-3185 Website: www.cytomx.com
What does Cytomx Therapeutics do?

CytomX Therapeutics is a NASDAQ-listed clinical-stage biopharmaceutical company dedicated to revolutionizing oncology treatments. The company utilizes its proprietary Probody® therapeutic platform to develop conditionally activated, masked biologic drugs. This technology is designed to localize drug activity specifically to the tumor microenvironme... nt, thereby increasing efficacy against cancer while minimizing damage and toxicity to healthy tissues throughout the rest of the body. CytomX's robust pipeline includes Probody drug conjugates (ADCs) and T-cell engaging bispecific antibodies, targeting unmet needs in solid tumors and other cancers. The company operates on a hybrid business model, generating revenue through extensive R&D and milestone payments from major strategic partnerships with pharmaceutical leaders like Bristol Myers Squibb and Amgen.Read More

What are Cytomx Therapeutics social media links?
Cytomx Therapeutics Linkedin page Cytomx Therapeutics Twitter page
Who invested in Cytomx Therapeutics?
Cytomx Therapeutics has 20 investors including Third Rock Ventures, Roche, Canaan Partners and Undisclosed.
Is Cytomx Therapeutics a public company?
Yes, Cytomx Therapeutics is a public company and is traded under the symbol CTMX
See more information about Cytomx Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.